Evidence map›Paper›PMID 20470049›Full record

ReviewThe Journal of infectious diseases2010

Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity.

Gerald I Byrne

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Genes · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Microorganisms · 2023
    Review
  8. Article
  9. Molecular Genotyping ofArchives of Razi Institute · 2022
    Article
  10. Predictive Values of SerumMicroorganisms · 2019
    Article
  11. Article
  12. Dynamic energy dependency ofThe Journal of biological chemistry · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gerald I ByrneDepartment of Molecular Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA. gbyrne@utmem.edu
University of Tennessee Health Science Center · US

Funding

IMMUNITY AND LATENCY TO CHLAMYDIAL INFECTIONSR01AI019782 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI BYRNE, GERALD IRWIN · 1985 to 2014
$4.7M
NIAID NIH HHS AI 19782NIAID NIH HHS R01 AI019782
6 · The paper itself

Abstract

An unanswered question concerning prevalence and disease severity of Chlamydia trachomatis genital infection is whether more prevalent strains or strains more likely to cause serious disease complications are causally associated with specific virulence attributes. The major method for distinguishing chlamydial strains is based on differences in the major outer membrane protein (MOMP). A subset of MOMP serovars (D and E serovars) are easily the most prevalent strains identified worldwide, but MOMP serovar and genovar analyses have not yielded consistent strain-dependent virulence distinctions. Expansion of the definitions of chlamydial strains beyond the MOMP paradigm are needed to better understand virulence properties for this pathogen and how these properties reflect disease severity. Substantive genetic and phenotypic differences have emerged for the 2 major C. trachomatis pathobiotypes associated with either trachoma or sexually transmitted diseases, but differences within the sexually transmitted disease group have not yielded reliable disease severity attributes. A number of candidate virulence factors have been identified, including the polymorphic outer membrane autotransporter family of proteins, the putative large cytotoxin, type III secretion effectors, stress response proteins, and proteins or other regulatory factors produced by the cryptic plasmid. Continued work on development of a chlamydial gene transfer system and application of genomic approaches to large collections of clinical isolates will be required to associate key chlamydial virulence factors with prevalence and disease severity in a definitive way.

Indexed as

Bacterial ProteinsBacterial ToxinsChlamydia InfectionsChlamydia trachomatisGlycolipidsHumansLipopolysaccharidesPhenotypePorinsPrevalenceSpecies SpecificityStress, PhysiologicalVirulence FactorsBacterial ProteinsBacterial ToxinsGlycolipidsLipopolysaccharidesomp1 protein, Chlamydia trachomatisPorinsVirulence Factors

Identifiers

PMID20470049
PMCPMC2878587
OpenAlexW2150355040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.